Stem cells give rise to tissue progenitor cells, which can differentiate into specific progenies and have potential use in regenerative medicine, disease treatment, and developmental biology. Efforts have been made to search for reliable biomarkers to identify stem cells ex vivo 1 and in vivo 2 so as to gain a better insight into the biology and physiology of stem cells, as well as to increase the selection efficiency from a given cell pool. However, many of the markers are invasive even in in vivo imaging approaches because stem cells were preloaded ex vivo by radionuclide, ferromagnetic, or reporter labeling,2 which decreases the clinical usefulness of these methods. Recently, a noninvasive biomarker using proton nuclear magnetic resonance spectroscopy has been identified for detection of neural stem and progenitor cells in the human brain in vivo. 3 Although the identity of this –detected biomarker is not known, it is suggestive of a metabolic profile of fatty acids. In fact, one generally accepted property of stem cells that differs from their differentiated progenies is a lower metabolic rate accompanied by a lower adenosine triphosphate (ATP) content.4 The shift from anaerobic glycolysis to the more efficient mitochondrial oxidative metabolism has been demonstrated in the differentiation of cardiomyocytes5 and human mesenchymal stem cells (hMSCs).6 The preference of stem cells to produce energy by glycolysis instead of oxidative phosphorylation is similar to that of cancer cells, which has been termed the Warburg effect.
Optical detection/imaging techniques have been employed to study cell metabolism in a noninvasive manner by monitoring the intrinsic fluorescence signal of reduced nicotinamide adenine dinucleotide (NADH), a key coenzyme in glycolysis and oxidative metabolism. Two measurement schemes are possible: fluorescence lifetime7 and fluorescence intensity.8 In the fluorescence lifetime measurement scheme, a fluorescence decay curve is typically fitted to a two-component exponential decay function , where and correspond to the short and long fluorescence lifetimes of NADH and were reported to be and for free and bound NADH, respectively.7 and are the corresponding relative amplitudes and . A mean fluorescence lifetime is defined as . Increased ratio and decreased and , and thus decreasing , were reported in perturbed human breast cells that had increased ratio (decreased metabolism).7 In the fluorescence intensity measurement scheme, NADH was often paired with another coenzyme in oxidative metabolism, flavin adenine dinucleotide (FAD), so that the oxidation-reduction state of cellular metabolism, NADH/FAD ratio, can be obtained. A decrease in the NADH/FAD ratio (increased metabolism) has been observed in MSCs after osteogenic differentiation for one week.8 Based on these findings, we hypothesized that the increase of metabolism during stem cell differentiation can be detected by the changes of NADH fluorescence lifetime (i.e., increased and decreased ratio). If successful, NADH fluorescence lifetime change can be a new optical probe for selecting stem cells from differentiated progenies. Furthermore, stem cell differentiation provides an excellent model system to study NADH fluorescence lifetime change in the context of metabolic change from glycolysis to oxidative phosphorylation. In this letter, we report the time course of change in the NADH fluorescence lifetime in response to osteogenic differentiation of hMSCs. This has been previously characterized by researchers in our research teams at the biochemical and molecular biological levels regarding the changes of mitochondrial biogenesis and antioxidant enzymes.6 Consistent with our hypothesis, we observed a decreased ratio and increased of NADH fluorescence lifetime during hMSC differentiation for up to using two-photon fluorescence lifetime imaging microscopy (FLIM).
Undifferentiated and osteogenically differentiated hMSCs were imaged with a two-photon laser scanning microscope and with a PlanApochromat oil objective lens (Olympus Corp., Japan) as previously reported.9 NADH fluorescence was excited at by a Verdi pumped mode-locked femtosecond Ti:sapphire laser (Coherent, Inc., Santa Clara, California) at . The emitted fluorescent light was bandpass filtered at (Edmund Optics, Inc., Barrington, New Jersey) at which NADH fluorescence emits maximally,7, 8 and was detected by a single-photon-counting photomultiplier tube (Hamamatus, Japan). Time-resolved detection was conducted by a single-photon-counting SPC-830 board (Becker & Hickl GmbH, Germany). Data were analyzed with the commercially available SPCImage software (Becker & Hickl GmbH) via a convolution of the two-component exponential decay function and the instrument response function (IRF), and then the convolved result was fitted to the actual data to derive lifetime parameters , , , , and . IRF was measured using a second-harmonic generated signal from a periodically poled lithium niobate crystal. Cell samples were prepared as described in our previous studies.6, 9 Bone marrow hMSCs were isolated and cultured in Iscove’s modified Dulbecco’s medium. hMSCs at a density of either 5000 or were seeded onto a -diam round glass coverslip for to allow a good attachment of hMSCs onto the coverslip. Differentiation of hMSCs was induced by further incubating these attached hMSCs in the osteogenic induction medium. Before and on days 7, 14, and 21 post induction of osteogenic differentiation, samples of cells were imaged. All samples were washed twice using phosphate-buffered saline, and were then placed in a cell chamber containing HEPES buffer as described previously.9 All images were taken at resolution with an acquisition time of for sufficient photon counts (at least several hundreds) per pixel. FLIM images were acquired at 1 to 3 sites per coverslip within approximately . The average laser power measured at the focal plane of the microscope objective was , which was lower than the reported laser power that caused damage to biological samples. Additional measurements were performed by repeatedly imaging the same sample 2 to 4 times within to confirm that no optical damage was introduced to our samples.
Figure 1 shows representative images of the NADH fluorescence lifetime of undifferentiated hMSCs [Fig. 1a] and differentiated hMSCs at days 7 [Fig. 1b], 14 [Fig. 1c] and 21 [Fig. 1d], respectively, at the cell density of . Each pixel represents the mean fluorescence lifetime and was color-coded between 500 (red) and (blue). Apparently, these images exhibited an NADH fluorescence lifetime shift (color changed) toward higher values during hMSC differentiation. The lifetime within a single cell was not homogeneous, for example, yellow, green, and blue colors were all seen in Fig. 1c. Figure 1e depicts the normalized histograms of shown in Figs. 1a, 1b, 1c, 1d. These histograms show that the peak of distribution shifted from a lower value in hMSCs to a higher value in the -differentiated hMSCs. The full width at half maximum of each histogram reflects the heterogeneous lifetime within an image that is in the range of . Similar images and histograms of , , , and were obtained using the same software (data not shown), and the corresponding mean value of each image was recorded for later averaging over multiple samples. The ratio was calculated by dividing the mean value of the image of by that of the image of .
The changes in NADH fluorescence lifetime from undifferentiated hMSCs to differentiated osteoblasts were confirmed in a series of samples (Table 1 and Fig. 2 ). At a cell density of , increased from to ps [Fig. 2a, solid line], and the ratio decreased from to [Fig. 2b, solid line] when hMSCs differentiated up to . These changes were statistically different as judged by a two-tailed Student’s test ( values ) and marked in the figure. and did not show continuous increase or decrease, although the values of most of the differentiated hMSCs are statistically different from those of undifferentiated hMSCs. In this study, we used the same culture of bone marrow hMSCs as that used in our previous study, in which a continuously increased ATP level was reported during hMSC differentiation.6 This ATP level change correlated well with the changes of and observed in this study, but not and .
The average values ( ±standard deviation) of mean τm and a1∕a2 for hMSCs (controls) and differentiated hMSCs at 7, 14, and 21days with higher (5000cells∕cm2) and lower (1000cells∕cm2) cell density, respectively, as well as the average values of τm and a1∕a2 for all cells and the corresponding p value between controls and differentiated hMSCs.
|Controls||Day 7||Day 14||Day 21|
Because stem cell density was reported to affect the cell metabolism and thus affect the NADH/FAD ratio,8 we acquired additional data at 5 times lower cell density ( ; Table 1 and Fig. 2) to see how the cell density influences NADH fluorescence lifetime and to test whether it affects the usefulness of NADH fluorescence lifetime technique in stem cell selection. Overall, we observed a similar trend of an increase in , a decrease in , and no continuous increase or decrease in and during hMSC differentiation. As expected, when the cell density is lower (lower metabolism), the and ratio tended to decrease and increase, respectively, although no change was seen in undifferentiated hMSCs. These changes between two cell densities at each time point of differentiation were not statistically different. We combined all data to increase the sample number for a better representative result of average populations (Table 1). The results demonstrate that the average and values of hMSCs are significantly different from those of differentiated hMSCs except that the ratio of -differentiated hMSCs is similar to that of hMSCs ( .
We have demonstrated that the changes in the and ratio are correlated well with the metabolic changes during hMSC differentiation. The results of this study suggest that hMSCs and their progenies can be differentiated, based on their metabolic differences, by a robust noninvasive optical technique through monitoring the NADH fluorescence lifetime. Alternative to the NADH fluorescence intensity measurement scheme in stem cell detection,8 a major advantage of the fluorescence lifetime measurement scheme is its insensitivity to the fluorescence intensity. Thus, clinical application of NADH fluorescence lifetime may be relatively easier than the fluorescence intensity measurement scheme regardless of the possible heterogeneity of the NADH spatial distribution.
We acknowledge financial support from "Aim for Top University Plan" from the Ministry of Education of Taiwan and Grant Nos. 95-2321B-010-001-YC, 95-2112-M-010-002, 95-2475-B-010-003-MY3, and NSC96-2320-B-010-006 from the National Science Council of Taiwan.
Y. Luo, J. Cai, I. Ginis, Y. Sun, S. Lee, S. X. Yu, A. Hoke, and M. Rao, “Designing, testing, and validating a focused stem cell microarray for characterization of neural stem cells and progenitor cells,” Stem Cells0250-6793 21(5), 575–587 (2003).Google Scholar
J. C. Wu, F. M. Bengel, and S. S. Gambhir, “Cardiovascular molecular imaging,” Radiology0033-8419 244(2), 337–355 (2007).Google Scholar
L. N. Manganas, X. Zhang, Y. Li, R. D. Hazel, S. D. Smith, M. E. Wagshul, F. Henn, H. Benveniste, P. M. Djuric, G. Enikolopov, and M. Maletic-Savatic, “Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain,” Science0036-8075 318(5852), 980–985 (2007).Google Scholar
T. Lonergan, B. Bavister, and C. Brenner, “Mitochondria in stem cells,” Mitochondrion1567-7249 7(5), 289–296 (2007).Google Scholar
S. Chung, P. P. Dzeja, R. S. Faustino, C. Perez-Terzic, A. Behfar, and A. Terzic, “Mitochondrial oxidative metabolism is required for the cardiac differentiation of stem cells,” Nat. Clin. Pract. Cardiovasc. Med. 4(Suppl 1), S60–67 (2007).Google Scholar
C. T. Chen, Y. V. Shih, T. K. Kuo, O. K. Lee, and Y. H. Wei, “Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells,” Stem Cells1066-5099 26(4), 960–968 (2008).Google Scholar
D. K. Bird, L. Yan, K. M. Vrotsos, K. W. Eliceiri, E. M. Vaughan, P. J. Keely, J. G. White, and N. Ramanujam, “Metabolic mapping of MCF10A human breast cells via multiphoton fluorescence lifetime imaging of the coenzyme NADH,” Cancer Res.0008-547210.1158/0008-5472.CAN-04-3922 65(19), 8766–8773 (2005).Google Scholar
J. M. Reyes, S. Fermanian, F. Yang, S. Y. Zhou, S. Herretes, D. B. Murphy, J. H. Elisseeff, and R. S. Chuck, “Metabolic changes in mesenchymal stem cells in osteogenic medium measured by autofluorescence spectroscopy,” Stem Cells1066-5099 24(5), 1213–1217 (2006).Google Scholar
H. W. Wang, V. Gukassyan, C. T. Chen, Y. H. Wei, H. W. Guo, J. S. Yu, and F. J. Kao, “Differentiation of apoptosis from necrosis by dynamic changes of reduced nicotinamide adenine dinucleotide (NADH) fluorescence lifetime in live cells,” J. Biomed. Opt.1083-366810.1117/1.2975831 13(5), 054011 (2008).Google Scholar